marmaduke, sorry for the confusion, but what I meant was; posters suggested that the company wasn't trying hard enough to sell HepaFat (or their marketing ability wasn't good enough), but in fact, they couldn't start selling it without the approval.
I'm not sure if it will actually take a while "before we get to grow revenue from patients to suitable levels", because of 3 simple reasons:
-"Resonance Health has strong credentials proving imaging core lab services to pharmaceutical companies for 10+ years"
- "Resonance Health has an established presence and relationships in these regions"
- Last but not least "Non-invasive", no pain
As mentioned by other posters before, because the company has established a relationship with hospitals, clinics etc with FerriScan (and gotten their trust), I would just imagine HepaFat would just roll through with little to no obstacles.
marmaduke, sorry for the confusion, but what I meant was;...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.57M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 116743 | 2 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable